Australia markets open in 5 hours 5 minutes

Spyre Therapeutics, Inc. (SYRE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.10-1.53 (-5.97%)
At close: 04:00PM EDT
24.10 0.00 (0.00%)
After hours: 04:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
688
886
2,329
18,739
0
Operating expenses
Research development
110,656
89,504
58,579
57,069
59,638
Selling general and administrative
47,564
39,946
28,531
27,319
21,843
Total operating expenses
158,220
129,450
87,110
84,388
81,481
Operating income or loss
-157,532
-128,564
-84,781
-65,649
-81,481
Total other income/expenses net
-216,810
-216,399
-7
-122
-5
Income before tax
-364,183
-338,816
-83,951
-65,660
-80,893
Income tax expense
42
-26
-136
141
0
Income from continuing operations
-364,225
-338,790
-83,815
-65,801
-80,893
Net income
-364,225
-338,790
-83,815
-65,801
-80,893
Net income available to common shareholders
-364,225
-338,790
-83,815
-65,801
-80,893
Basic EPS
-74.15
-49.12
-24.75
-25.00
-38.00
Diluted EPS
-74.15
-49.12
-24.75
-25.00
-38.00
Basic average shares
3,925
6,897
3,371
2,630
2,135
Diluted average shares
3,925
6,897
3,371
2,630
2,135